Get started
Award

V2021-026

Funded outputs count: 6
Funder award ID: V2021-026
OpenAlex ID: G5335202808
Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis
2026 · Rima Singh, Natalie Yousefian, et al. · Cellular and Molecular Gastroenterology and Hepatology · 1
Cancer-associated fibroblasts regulate DNA repair in pancreatic cancer through NDRG1-mediated R-loop processing
2026 · Nina Kozlova, Kayla A. Cruz, et al. · Nature Cell Biology · 2
Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer
2025 · Alica K. Beutel, Sabrina Calderon, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Barriers and opportunities for gemcitabine in pancreatic cancer therapy
2022 · Alica K. Beutel, Christopher J. Halbrook · American Journal of Physiology-Cell Physiology · 148
Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells
2022 · Christopher J. Halbrook, Galloway Thurston, et al. · Nature Cancer · 78
PDF
Multiomic characterization of pancreatic cancer-associated macrophage polarization reveals deregulated metabolic programs driven by the GM-CSF–PI3K pathway
2022 · Seth Boyer, Ho-Joon Lee, et al. · eLife · 56
Year
Topic